Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Bile Duct Neoplasms
×
pembrolizumab
×
Clear all
Filters
3
NCT05346484
2026-03-06
MAST
Imugene Limited
Phase 1
Terminated
66 enrolled